Oxidative burst capacity of neutrophils.

<p>Panel A and B show the burst rate (B-R) in patients treated with triple therapy and IFN-free regimen, respectively. Panel C and D show the enzymatic activity per cell (median fluorescence intensity, B-MFI) in patients treated with triple therapy and IFN-free regimen, respectively. Data are analyzed at baseline (before starting antiviral therapy), and at week 4 and 8 of therapy. * These comparisons were performed by Friedman tests.</p

Oxidative burst capacity of monocytes.

<p>Panel A and B show the burst rate (B-R) in patients treated with triple therapy and IFN-free regimen, respectively. Panel C and D show the enzymatic activity per cell (median fluorescence intensity, B-MFI) in patients treated with triple therapy and IFN-free regimen, respectively. Data are analyzed at baseline (before starting antiviral therapy, n = 28), and at week 4 and 8 of therapy. * These comparisons were performed by Friedman tests.</p

Demographic, clinical and virological characteristics of the patients included in the study.

<p>Demographic, clinical and virological characteristics of the patients included in the study.</p